 |
市場調查報告書
商品編碼
2050646
凍乾藥品市場：依藥物類別、適應症、包裝類型、通路及地區分類Lyophilized Drugs Market, By Drug Class, By Indication, By Packaging Type, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計到2026年，冷凍乾燥藥品市場規模將達到4056億美元，到2033年將達到7,558.6億美元。預計從2026年到2033年，其複合年成長率將達到9.3%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 4056億美元 |
| 歷史數據時期： | 2020-2024 | 預測期： | 2026-2033 |
| 2026年至2033年預測期間的複合年成長率： | 9.30% | 2033年市場規模預測： | 7558.6億美元 |
全球凍乾藥品市場成長的驅動力在於凍乾藥品具有許多優勢，包括穩定性提升、給藥方便、運輸成本降低。冷凍乾燥通過去除製劑中的水分，抑制微生物生長，從而延長藥品的保存期限。此外，冷凍乾燥也使得藥品無需冷藏即可儲存和運輸。隨著慢性病盛行率的上升以及製藥公司在新型藥物遞送解決方案研發方面投入的不斷增加，預計在預測期內，冷凍乾燥藥品的需求將顯著成長。
市場動態
全球凍乾藥品市場成長的主要促進因素包括老年人口的成長、慢性病盛行率的上升以及冷凍乾燥藥物具有的許多優勢，例如更長的保存期限和更低的微生物污染風險。然而，凍乾設備和製程的高成本預計將抑制市場成長。另一方面，亞太和拉丁美洲等新興市場由於醫療基礎設施的改善和醫療支出的成長，預計將為市場相關人員創造良好的商機。此外，對新型高效凍乾技術的持續研發預計將在預測期內進一步推動全球市場的擴張。
本研究的關鍵特徵
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數創建了全球凍乾藥品市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 這份《全球凍乾藥品市場報告》旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過分析全球凍乾藥品市場中使用的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- 一致性機會圖（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 影響分析
- 市場趨勢
- 監管趨勢
- 收購與合作趨勢
- 資金籌措及投資
- PEST分析
- 波特的分析
第4章 全球凍乾藥品市場：依藥物類別分類，2021-2033年
- 概述
- 抗感染藥物
- 抗癌藥物
- 利尿劑
- 質子幫浦抑制劑
- 麻醉劑
- 抗凝血劑
- NSAIDs
- 其他
第5章 全球凍乾藥品市場：依包裝類型分類，2021-2033年
- 概述
- 管瓶
- 注射藥物
- 墨水匣
第6章 全球凍乾藥品市場：依通路分類，2021-2033年
- 概述
- 醫院藥房
- 零售藥房
- 網路藥房
第7章 全球凍乾藥品市場：依適應症分類，2021-2033年
- 概述
- 腫瘤學
- 感染疾病
- 自體免疫疾病
- 消化系統疾病
- 皮膚病
- 呼吸系統疾病
- 眼科疾病
- 荷爾蒙失調
- 其他
第8章 全球凍乾藥品市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第9章 競爭情勢
- 公司簡介
- Pfizer Inc.
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Sanofi SA
- Amgen Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Bristol Myers Squibb Company
- GlaxoSmithKline plc
- Gilead Sciences, Inc.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan NV
- Celgene Corporation
- Novo Nordisk A/S
- Vertex Pharmaceuticals Incorporated
- Takeda Pharmaceutical Company Limited
第10章 分析師建議
- 機會分析
- 一致的機會地圖
第11章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI2930
Lyophilized Drugs Market is estimated to be valued at USD 405.60 Bn in 2026 and is expected to reach USD 755.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 405.60 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.30% | 2033 Value Projection: | USD 755.86 Bn |
The global lyophilized drugs market growth is driven by various advantages associated with lyophilization of drugs such as improved stability, ease of administration, and reduced transportation costs. Lyophilization or freeze-drying helps extend the shelf life of drugs by removing water from the formulations, thereby preventing the growth of microorganisms. It also enables storage and transportation of drugs without refrigeration. With the growing prevalence of chronic diseases and increasing R&D investments of pharmaceutical companies in novel drug delivery solutions, the demand for lyophilized drugs is expected to rise substantially during the forecast period.
Market Dynamics
The global lyophilized drugs market is driven by the growing geriatric population, rising incidence of chronic diseases, and advantages of lyophilized drugs such as longer shelf life and lower risk of microbial contamination. However, high costs associated with lyophilization equipment and procedures are expected to restrain the market growth. On the other hand, emerging markets of Asia Pacific and Latin America are likely to offer lucrative opportunities for market players owing to improving healthcare infrastructure and increasing healthcare spending in these regions. Additionally, ongoing research for development of novel and more efficient lyophilization technologies will further create opportunities for the expansion of the global market during the forecast period.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lyophilized drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Jadavpur University, Merck & Co., Inc., and GlaxoSmithKline plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global lyophilized drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lyophilized drugs market.
Market Segmentation
- Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Anti-infective
- Antineoplastic
- Diuretics
- Proton Pump Inhibitor
- Anesthetic
- Anticoagulant
- NSAID's
- Others
- Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Oncology
- Infectious Disease
- Autoimmune Disease
- Gastrointestinal Disease
- Dermatological Disorders
- Respiratory Diseases
- Ophthalmic Diseases
- Hormonal Disorders
- Others
- Packaging Type Insights (Revenue, USD Bn, 2021 - 2033)
- Vial
- Injection
- Cartridge
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Novartis AG
- Roche Holding AG
- Johnson & Johnson
- Sanofi S.A.
- Amgen Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- Bristol Myers Squibb Company
- GlaxoSmithKline plc
- Gilead Sciences, Inc.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Celgene Corporation
- Novo Nordisk A/S
- Vertex Pharmaceuticals Incorporated
- Takeda Pharmaceutical Company Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Indication
- Market Snapshot, By Packaging Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Lyophilized Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Anti-infective
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Antineoplastic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diuretics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Proton Pump Inhibitor
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anesthetic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anticoagulant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- NSAID's
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Lyophilized Drugs Market, By Packaging Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Vial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Injection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cartridge
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Lyophilized Drugs Market, By Distribution Channel , 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Lyophilized Drugs Market, By Indication, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Infectious Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Autoimmune Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Gastrointestinal Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Dermatological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ophthalmic Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hormonal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Lyophilized Drugs Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel2019 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vertex Pharmaceuticals Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
02-2729-4219
+886-2-2729-4219
脾氨肽口服凍乾粉市場：依產品類型、應用、通路和最終用戶分類－2026-2032年全球預測
2026-2034年全球冷凍乾燥注射劑市場規模、佔有率、趨勢和成長分析報告
冷凍乾燥注射劑市場－全球產業規模、佔有率、趨勢、機會與預測：包裝、劑量、適應症、終端用戶、地區和競爭格局，2021-2031年重組膠原蛋白凍乾纖維市場按類型、形式、應用和最終用戶分類 - 全球預測 2026-2032
凍乾試劑珠：全球市佔率及排名、總收入及需求預測（2025-2031年）
冷凍乾燥藥物、重組器材和注射市場：產品、市場、療法、策略和預測
冷凍乾燥試劑珠的全球市場（2024）